A decade and a half of protein intrinsic disorder: Biology still waits for physics

Protein Science

Volumn 22, Issue 6, 2013, Pages 693-724

  Uversky, Vladimir N ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b INSTITUTE FOR BIOLOGICAL INSTRUMENTATION   (Russian Federation)

Author keywords

Intrinsically disordered protein; Intrinsically disordered protein region; Partially folded protein; Protein evolution; Protein function; Protein structure; Protein protein interaction

Indexed keywords

INTRINSICALLY DISORDERED PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; EVOLUTION; HYDRODYNAMICS; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFECT; PROTEIN INTRINSIC DISORDER; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; REVIEW; SCIENTIST;

ANIMALS; EVOLUTION, MOLECULAR; HUMANS; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN INTERACTION MAPS; PROTEINS;

EID: 84878940937     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.2261     Document Type: Review

References (310)

1. Uversky VN (2002) Natively unfolded proteins: a point where biology waits for physics. Protein Sci 11:739- 756.
2. Fischer E (1894) Einfluss der configuration auf die wirkung der enzyme. Ber Dt Chem Ges 27:2985-2993.
3. Bernstein FC, Koetzle TF, Williams GJ, Meyer EF, Jr, Brice MD, Rodgers JR, Kennard O, Shimanouchi T, Tasumi M (1977) The Protein Data Bank: a computerbased archival file for macromolecular structures. J Mol Biol 112:535-542.
4. Uversky VN, Dunker AK (2010) Understanding protein non-folding. Biochim Biophys Acta 1804:1231-1264.
5. Kuhn TS (2012) The structure of scientific revolutions. Chicago: University Of Chicago Press.
6. Petsko GA, Ringe D. 2004. Primers in biology. Protein structure and function. London: New Science Press Ltd., Sinauer Associates, Inc. Publishers, Blackwell Publishing.
7. Bloomer AC, Champness JN, Bricogne G, Staden R, Klug A (1978) Protein disk of tobacco mosaic virus at 2.8 A resolution showing the interactions within and between subunits. Nature 276:362-368.
8. Bode W, Schwager P, Huber R (1978) The transition of bovine trypsinogen to a trypsin-like state upon strong ligand binding. The refined crystal structures of the bovine trypsinogen-pancreatic trypsin inhibitor complex and of its ternary complex with Ile-Val at 1.9 A resolution. J Mol Biol 118:99-112.
9. Le Gall T, Romero PR, Cortese MS, Uversky VN, Dunker AK (2007) Intrinsic disorder in the Protein Data Bank. J Biomol Struct Dyn 24:325-342.
10. Dunker AK, Garner E, Guilliot S, Romero P, Albrecht K, Hart J, Obradovic Z, Kissinger C, Villafranca JE (1998) Protein disorder and the evolution of molecular recognition: theory, predictions and observations. Pac Symp Biocomput 473-484.
11. Wright PE, Dyson HJ (1999) Intrinsically unstructured proteins: re-assessing the protein structure- function paradigm. J Mol Biol 293:321-331.
12. Uversky VN, Gillespie JR, Fink AL (2000) Why are "natively unfolded" proteins unstructured under physiologic conditions? Proteins 41:415-427.
13. Dunker AK, Lawson JD, Brown CJ, Williams RM, Romero P, Oh JS, Oldfield CJ, Campen AM, Ratliff CM, Hipps KW, Ausio J, Nissen MS, Reeves R, Kang C, Kissinger CR, Bailey RW, Griswold MD, Chiu W, Garner EC, Obradovic Z (2001) Intrinsically disordered protein. J Mol Graph Model 19:26-59.
14. Tompa P (2002) Intrinsically unstructured proteins. Trends Biochem Sci 27:527-533.
15. Daughdrill GW, Pielak GJ, Uversky VN, Cortese MS, Dunker AK. Natively disordered proteins. In: Buchner J, Kiefhaber T, Eds. (2005) Handbook of protein folding. Weinheim, Germany: Wiley-VCH, Verlag GmbH & Co. KGaA, pp. 271-353.
16. Dunker AK, Babu MM, Barbar E, Blackledge M, Bondos SE, Dosztanyi Z, Dyson HJ, Forman-Kay J, Fuxreiter M, Gsponer J, Han K-H, Jones DT, Longhi S, Metallo SJ, Nishikawa K, Nussinov R, Obradovic Z, Pappu R, Rost B, Selenko P, Subramaniam V, Sussman JL, Tompa P, Uversky VN (2013) What's in a name? Why these proteins are intrinsically disordered. Intrinsically Disordered Proteins 1:e24157.
17. Holt C, Sawyer L (1993) Caseins as rheomorphic proteins: interpretation of primary and secondary structures of the as1-, b-, and k-caseins. J Chem Soc Faraday Trans 89:2683-2692.
18. Pullen RA, Jenkins JA, Tickle IJ, Wood SP, Blundell TL (1975) The relation of polypeptide hormone structure and flexibility to receptor binding: the relevance of X-ray studies on insulins, glucagon and human placental lactogen. Mol Cell Biochem 8:5-20.
19. Cary PD, Moss T, Bradbury EM (1978) High-resolution proton-magnetic- resonance studies of chromatin core particles. Eur J Biochem 89:475-482.
20. Linderstrom-Lang K, Schellman JA. Protein structure and enzyme activity. In: Boyer PD, Lardy H, Myrback K, Eds. (1959) The enzymes. New York: Academic Press, pp 443-510.
21. Schweers O, Schonbrunn-Hanebeck E, Marx A, Mandelkow E (1994) Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure. J Biol Chem 269:24290-24297.
22. Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT, Jr (1996) NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35:13709-13715.
23. Chen J, Liang H, Fernandez A (2008) Protein structure protection commits gene expression patterns. Genome Biol 9:R107.
24. Uversky VN (2003) A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders. J Biomol Struct Dyn 21:211-234.
25. Fuxreiter M, Tompa P, Simon I, Uversky VN, Hansen JC, Asturias FJ (2008) Malleable machines take shape in eukaryotic transcriptional regulation. Nat Chem Biol 4:728-737.
26. Tsvetkov P, Asher G, Paz A, Reuven N, Sussman JL, Silman I, Shaul Y (2008) Operational definition of intrinsically unstructured protein sequences based on susceptibility to the 20S proteasome. Proteins 70:1357-1366.
27. Dunker AK, Uversky VN (2010) Drugs for 'protein clouds': targeting intrinsically disordered transcription factors. Curr Opin Pharmacol 10:782-788.
28. Livesay DR (2010) Protein dynamics: dancing on an ever-changing free energy stage. Curr Opin Pharmacol 10:706-708.
29. Janin J, Sternberg MJE (2013) Protein flexibility, not disorder, is intrinsic to molecular recognition. F1000 Biol Rep 5:2.
30. Campen A, Williams RM, Brown CJ, Meng J, Uversky VN, Dunker AK (2008) TOP-IDP-scale: a new amino acid scale measuring propensity for intrinsic disorder. Protein Pept Lett 15:956-963.
31. Radivojac P, Iakoucheva LM, Oldfield CJ, Obradovic Z, Uversky VN, Dunker AK (2007) Intrinsic disorder and functional proteomics. Biophys J 92:1439-1456.
32. Romero P, Obradovic Z, Li X, Garner EC, Brown CJ, Dunker AK (2001) Sequence complexity of disordered protein. Proteins 42:38-48.
33. Garner E, Cannon P, Romero P, Obradovic Z, Dunker AK (1998) Predicting disordered regions from amino acid sequence: common themes despite differing structural characterization. Genome Inform Ser Workshop Genome Inform 9:201-213.
34. Williams RM, Obradovi Z, Mathura V, Braun W, Garner EC, Young J, Takayama S, Brown CJ, Dunker AK (2001) The protein non-folding problem: amino acid determinants of intrinsic order and disorder. Pac Symp Biocomput 89-100.
35. Vacic V, Uversky VN, Dunker AK, Lonardi S (2007) Composition Profiler: a tool for discovery and visualization of amino acid composition differences. BMC Bioinformatics 8:211.
36. Li X, Obradovic Z, Brown CJ, Garner EC, Dunker AK (2000) Comparing predictors of disordered protein. Genome Inform Ser Workshop Genome Inform 11:172-184.
37. Ferron F, Longhi S, Canard B, Karlin D (2006) A practical overview of protein disorder prediction methods. Proteins 65:1-14.
38. Bourhis JM, Canard B, Longhi S (2007) Predicting protein disorder and induced folding: from theoretical principles to practical applications. Curr Protein Pept Sci 8:135-149.
39. Dosztanyi Z, Sandor M, Tompa P, Simon I (2007) Prediction of protein disorder at the domain level. Curr Protein Pept Sci 8:161-171.
40. Dosztanyi Z, Tompa P (2008) Prediction of protein disorder. Methods Mol Biol 426:103-115.
41. He B, Wang K, Liu Y, Xue B, Uversky VN, Dunker AK (2009) Predicting intrinsic disorder in proteins: an overview. Cell Res 19:929-949.
42. Jin F, Liu Z (2013) Inherent relationships among different biophysical prediction methods for intrinsically disordered proteins. Biophys J 104:488-495.
43. Dunker AK, Obradovic Z, Romero P, Garner EC, Brown CJ (2000) Intrinsic protein disorder in complete genomes. Genome Inform Ser Workshop Genome Inform 11:161-171.
44. Ward JJ, Sodhi JS, McGuffin LJ, Buxton BF, Jones DT (2004) Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. J Mol Biol 337:635-645.
45. Uversky VN (2010) The mysterious unfoldome: structureless, underappreciated, yet vital part of any given proteome. J Biomed Biotechnol 2010:568068.
46. Xue B, Dunker AK, Uversky VN (2012) Orderly order in protein intrinsic disorder distribution: disorder in 3500 proteomes from viruses and the three domains of life. J Biomol Struct Dyn 30:137-149.
47. Romero P, Obradovic Z, Kissinger CR, Villafranca JE, Garner E, Guilliot S, Dunker AK (1998) Thousands of proteins likely to have long disordered regions. Pac Symp Biocomput 437-448.
48. Feng ZP, Zhang X, Han P, Arora N, Anders RF, Norton RS (2006) Abundance of intrinsically unstructured proteins in P. falciparum and other apicomplexan parasite proteomes. Mol Biochem Parasitol 150:256-267.
49. Tompa P, Dosztanyi Z, Simon I (2006) Prevalent structural disorder in E. coli and S. cerevisiae proteomes. J Proteome Res 5:1996-2000.
50. Galea CA, High AA, Obenauer JC, Mishra A, Park CG, Punta M, Schlessinger A, Ma J, Rost B, Slaughter CA, Kriwacki RW (2009) Large-scale analysis of thermostable, mammalian proteins provides insights into the intrinsically disordered proteome. J Proteome Res 8:211-226.
51. Xue B, Williams RW, Oldfield CJ, Dunker AK, Uversky VN (2010) Archaic chaos: intrinsically disordered proteins in Archaea. BMC Syst Biol 4 (SUPPL. 1):S1.
52. Burra PV, Kalmar L, Tompa P (2010) Reduction in structural disorder and functional complexity in the thermal adaptation of prokaryotes. PLoS One 5:e12069.
53. Mohan A, Sullivan WJ, Jr., Radivojac P, Dunker AK, Uversky VN (2008) Intrinsic disorder in pathogenic and non-pathogenic microbes: discovering and analyzing the unfoldomes of early-branching eukaryotes. Mol Biosyst 4:328-340.
54. Dryden DT, Thomson AR, White JH (2008) How much of protein sequence space has been explored by life on Earth? J R Soc Interface 5:953-956.
55. Wathen B, Jia Z (2009) Folding by numbers: primary sequence statistics and their use in studying protein folding. Int J Mol Sci 10:1567-1589.
56. Lau KF, Dill KA (1990) Theory for protein mutability and biogenesis. Proc Natl Acad Sci USA 87:638-642.
57. Chan HS, Dill KA (1991) Polymer principles in protein structure and stability. Annu Rev Biophys Biophys Chem 20:447-490.
58. Cordes MH, Davidson AR, Sauer RT (1996) Sequence space, folding and protein design. Curr Opin Struct Biol 6:3-10.
59. Riddle DS, Santiago JV, Bray-Hall ST, Doshi N, Grantcharova VP, Yi Q, Baker D (1997) Functional rapidly folding proteins from simplified amino acid sequences. Nat Struct Biol 4:805-809.
60. Plaxco KW, Riddle DS, Grantcharova V, Baker D (1998) Simplified proteins: minimalist solutions to the 'protein folding problem'. Curr Opin Struct Biol 8:80-85.
61. Larson SM, England JL, Desjarlais JR, Pande VS (2002) Thoroughly sampling sequence space: largescale protein design of structural ensembles. Protein Sci 11:2804-2813.
62. Guo HH, Choe J, Loeb LA (2004) Protein tolerance to random amino acid change. Proc Natl Acad Sci USA 101:9205-9210.
63. Doi N, Kakukawa K, Oishi Y, Yanagawa H (2005) High solubility of random-sequence proteins consisting of five kinds of primitive amino acids. Protein Eng Des Sel 18:279-284.
64. White SH, Jacobs RE (1990) Statistical distribution of hydrophobic residues along the length of protein chains. Implications for protein folding and evolution. Biophys J 57:911-921.
65. Murphy LR, Wallqvist A, Levy RM (2000) Simplified amino acid alphabets for protein fold recognition and implications for folding. Protein Eng 13:149-152.
66. Etchebest C, Benros C, Bornot A, Camproux AC, de Brevern AG (2007) A reduced amino acid alphabet for understanding and designing protein adaptation to mutation. Eur Biophys J 36:1059-1069.
67. Wang J, Wang W (1999) A computational approach to simplifying the protein folding alphabet. Nat Struct Biol 6:1033-1038.
68. Uversky VN (2013) Unusual biophysics of intrinsically disordered proteins. Biochim Biophys Acta 1834:932- 951.
69. Uversky VN, Dunker AK (2013) The case for intrinsically disordered proteins playing contributory roles in molecular recognition without a stable 3D structure. F1000 Biol Rep 5:1.
70. Tompa P (2005) The interplay between structure and function in intrinsically unstructured proteins. FEBS Lett 579:3346-3354.
71. Dunker AK, Brown CJ, Obradovic Z (2002) Identification and functions of usefully disordered proteins. Adv Protein Chem 62:25-49.
72. Dunker AK, Brown CJ, Lawson JD, Iakoucheva LM, Obradovic Z (2002) Intrinsic disorder and protein function. Biochemistry 41:6573-6582.
73. Uversky VN (2002) What does it mean to be natively unfolded? Eur J Biochem 269:2-12.
74. Fuxreiter M, Tompa P (2012) Fuzzy complexes: a more stochastic view of protein function. Adv Exp Med Biol 725:1-14.
75. Tompa P, Fuxreiter M (2008) Fuzzy complexes: polymorphism and structural disorder in protein-protein interactions. Trends Biochem Sci 33:2-8.
76. Uversky VN (in press) Intrinsic disorder-based protein interactions and their modulators. Curr Pharm Des.
77. Oldfield CJ, Meng J, Yang JY, Yang MQ, Uversky VN, Dunker AK (2008) Flexible nets: disorder and induced fit in the associations of p53 and 14-3-3 with their partners. BMC Genomics 9 (SUPPL. 1):S1.
78. Uversky VN, Oldfield CJ, Dunker AK (2005) Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling. J Mol Recognit 18:343- 384.
79. Dunker AK, Obradovic Z (2001) The protein trinity - linking function and disorder. Nat Biotechnol 19:805- 806.
80. Ma B, Kumar S, Tsai CJ, Nussinov R (1999) Folding funnels and binding mechanisms. Protein Eng 12:713-720.
81. Ptitsyn O (1995) Molten globule and protein folding. Adv Protein Chem 47:83-229.
82. Tcherkasskaya O, Uversky VN (2003) Polymeric aspects of protein folding: a brief overview. Protein Pept Lett 10:239-245.
83. Vitalis A, Pappu RV (2009) ABSINTH: a new continuum solvation model for simulations of polypeptides in aqueous solutions. J Comput Chem 30:673-699.
84. Vitalis A, Wang X, Pappu RV (2007) Quantitative characterization of intrinsic disorder in polyglutamine: insights from analysis based on polymer theories. Biophys J 93:1923-1937.
85. Vitalis A, Wang X, Pappu RV (2008) Atomistic simulations of the effects of polyglutamine chain length and solvent quality on conformational equilibria and spontaneous homodimerization. J Mol Biol 384:279-297.
86. Wang X, Vitalis A, Wyczalkowski MA, Pappu RV (2006) Characterizing the conformational ensemble of monomeric polyglutamine. Proteins 63:297-311.
87. Williamson TE, Vitalis A, Crick SL, Pappu RV (2010) Modulation of polyglutamine conformations and dimer formation by the N-terminus of huntingtin. J Mol Biol 396:1295-1306.
88. Tran HT, Mao A, Pappu RV (2008) Role of backbonesolvent interactions in determining conformational equilibria of intrinsically disordered proteins. J Am Chem Soc 130:7380-7392.
89. Mao AH, Crick SL, Vitalis A, Chicoine CL, Pappu RV (2010) Net charge per residue modulates conformational ensembles of intrinsically disordered proteins. Proc Natl Acad Sci USA 107:8183-8188.
90. Muller-Spath S, Soranno A, Hirschfeld V, Hofmann H, Ruegger S, Reymond L, Nettels D, Schuler B (2010) From the cover: charge interactions can dominate the dimensions of intrinsically disordered proteins. Proc Natl Acad Sci USA 107:14609-14614.
91. Oldfield CJ, Cheng Y, Cortese MS, Brown CJ, Uversky VN, Dunker AK (2005) Comparing and combining predictors of mostly disordered proteins. Biochemistry 44:1989-2000.
92. Ashbaugh HS, Hatch HW (2008) Natively unfolded protein stability as a coil-to-globule transition in charge/hydropathy space. J Am Chem Soc 130:9536- 9542.
93. Patil A, Nakamura H (2006) Disordered domains and high surface charge confer hubs with the ability to interact with multiple proteins in interaction networks. FEBS Lett 580:2041-2045.
94. Yamada J, Phillips JL, Patel S, Goldfien G, Calestagne- Morelli A, Huang H, Reza R, Acheson J, Krishnan VV, Newsam S, Gopinathan A, Lau EY, Colvin ME, Uversky VN, Rexach MF (2010) A bimodal distribution of two distinct categories of intrinsically disordered structures with separate functions in FG nucleoporins. Mol Cell Proteomics 9:2205-2224.
95. Uversky VN (2009) Intrinsically disordered proteins and their environment: effects of strong denaturants, temperature, pH, counter ions, membranes, binding partners, osmolytes, and macromolecular crowding. Protein J 28:305-325.
96. Uversky VN, Li J, Fink AL (2001) Evidence for a partially folded intermediate in alpha-synuclein fibril formation. J Biol Chem 276:10737-10744.
97. Permyakov SE, Millett IS, Doniach S, Permyakov EA, Uversky VN (2003) Natively unfolded C-terminal domain of caldesmon remains substantially unstructured after the effective binding to calmodulin. Proteins 53:855-862.
98. Uversky VN, Permyakov SE, Zagranichny VE, Rodionov IL, Fink AL, Cherskaya AM, Wasserman LA, Permyakov EA (2002) Effect of zinc and temperature on the conformation of the gamma subunit of retinal phosphodiesterase: a natively unfolded protein. J Proteome Res 1:149-159.
99. Uversky VN, Gillespie JR, Millett IS, Khodyakova AV, Vasiliev AM, Chernovskaya TV, Vasilenko RN, Kozlovskaya GD, Dolgikh DA, Fink AL, Doniach S, Abramov VM (1999) Natively unfolded human prothymosin alpha adopts partially folded collapsed conformation at acidic pH. Biochemistry 38:15009-15016.
100. Konno T, Tanaka N, Kataoka M, Takano E, Maki M (1997) A circular dichroism study of preferential hydration and alcohol effects on a denatured protein, pig calpastatin domain I. Biochim Biophys Acta 1342:73-82.
101. Lynn A, Chandra S, Malhotra P, Chauhan VS (1999) Heme binding and polymerization by Plasmodium falciparum histidine rich protein. II. Influence of pH on activity and conformation. FEBS Lett 459:267-271.
102. Johansson J, Gudmundsson GH, Rottenberg ME, Berndt KD, Agerberth B (1998) Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem 273:3718-3724.
103. Magidovich E, Fleishman SJ, Yifrach O (2006) Intrinsically disordered C-terminal segments of voltage- activated potassium channels: a possible fishing rod-like mechanism for channel binding to scaffold proteins. Bioinformatics 22:1546-1550.
104. Roy S, Schnell S, Radivojac P (2006) Unraveling the nature of the segmentation clock: intrinsic disorder of clock proteins and their interaction map. Comput Biol Chem 30:241-248.
105. Minezaki Y, Homma K, Nishikawa K (2007) Intrinsically disordered regions of human plasma membrane proteins preferentially occur in the cytoplasmic segment. J Mol Biol 368:902-913.
106. De Biasio A, Guarnaccia C, Popovic M, Uversky VN, Pintar A, Pongor S (2008) Prevalence of intrinsic disorder in the intracellular region of human single-pass type I proteins: the case of the notch ligand Delta-4. J Proteome Res 7:2496-2506.
107. Yang JY, Yang MQ, Dunker AK, Deng Y, Huang X (2008) Investigation of transmembrane proteins using a computational approach. BMC Genomics 9 (SUPPL. 1):S7.
108. Xue B, Li L, Meroueh SO, Uversky VN, Dunker AK (2009) Analysis of structured and intrinsically disordered regions of transmembrane proteins. Mol Biosyst 5:1688-1702.
109. Lenard J, Singer SJ (1966) Protein conformation in cell membrane preparations as studied by optical rotatory dispersion and circular dichroism. Proc Natl Acad Sci USA 56:1828-1835.
110. Rosenbusch JP (1974) Characterization of the major envelope protein from Escherichia coli. Regular arrangement on the peptidoglycan and unusual dodecyl sulfate binding. J Biol Chem 249:8019-8029.
111. Dunker AK, Jones TC (1978) Proposed knobs-intoholes packing for several membrane proteins. Membr Biochem 2:1-16.
112. Paul C, Rosenbusch JP (1985) Folding patterns of porin and bacteriorhodopsin. EMBO J 4:1593-1597.
113. Rees DC, DeAntonio L, Eisenberg D (1989) Hydrophobic organization of membrane proteins. Science 245:510-513.
114. Stevens TJ, Arkin IT (1999) Are membrane proteins "inside-out" proteins? Proteins 36:135-143.
115. Rees DC, Eisenberg D (2000) Turning a reference inside-out: commentary on an article by Stevens and Arkin entitled: "Are membrane proteins 'inside-out' proteins?" (Proteins 1999;36:135-143). Proteins 38:121-122.
116. Von Heijne G (1986) The distribution of positively charged residues in bacterial innter membrane proteins correlates with the transmembrane topology. EMBO J 5:3021-3027.
117. Bernsel A, Viklund H, Falk J, Lindahl E, von Heijne G, Elofsson A (2008) Prediction of membrane-protein topology from first principles. Proc Natl Acad Sci USA 105:7177-7181.
118. Siglioccolo A, Paiardini A, Piscitelli M, Pascarella S (2011) Structural adaptation of extreme halophilic proteins through decrease of conserved hydrophobic contact surface. BMC Struct Biol 11:50.
119. Zaccai G, Eisenberg H (1990) Halophilic proteins and the influence of solvent on protein stabilization. Trends Biochem Sci 15:333-337.
120. Madern D, Ebel C, Zaccai G (2000) Halophilic adaptation of enzymes. Extremophiles 4:91-98.
121. Mevarech M, Frolow F, Gloss LM (2000) Halophilic enzymes: proteins with a grain of salt. Biophys Chem 86:155-164.
122. Wright DB, Banks DD, Lohman JR, Hilsenbeck JL, Gloss LM (2002) The effect of salts on the activity and stability of Escherichia coli and Haloferax volcanii dihydrofolate reductases. J Mol Biol 323:327-344.
123. Bergqvist S, Williams MA, O'Brien R, Ladbury JE (2003) Halophilic adaptation of protein-DNA interactions. Biochem Soc Trans 31:677-680.
124. Fukuchi S, Yoshimune K, Wakayama M, Moriguchi M, Nishikawa K (2003) Unique amino acid composition of proteins in halophilic bacteria. J Mol Biol 327:347-357.
125. Paul S, Bag SK, Das S, Harvill ET, Dutta C (2008) Molecular signature of hypersaline adaptation: insights from genome and proteome composition of halophilic prokaryotes. Genome Biol 9:R70.
126. Tadeo X, Lopez-Mendez B, Trigueros T, Lain A, Castano D, Millet O (2009) Structural basis for the aminoacid composition of proteins from halophilic archea. PLoS Biol 7:e1000257.
127. Elcock AH, McCammon JA (1998) Electrostatic contributions to the stability of halophilic proteins. J Mol Biol 280:731-748.
128. Xue B, Williams RW, Oldfield CJ, Goh GK, Dunker AK, Uversky VN (2010) Viral disorder or disordered viruses: do viral proteins possess unique features? Protein Pept Lett 17:932-951.
129. Berezovsky IN (2011) The diversity of physical forces and mechanisms in intermolecular interactions. Phys Biol 8:035002.
130. Iakoucheva LM, Brown CJ, Lawson JD, Obradovic Z, Dunker AK (2002) Intrinsic disorder in cell-signaling and cancer-associated proteins. J Mol Biol 323:573-584.
131. Dyson HJ, Wright PE (2002) Coupling of folding and binding for unstructured proteins. Curr Opin Struct Biol 12:54-60.
132. Dyson HJ, Wright PE (2005) Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Biol 6:197-208.
133. Fink AL (2005) Natively unfolded proteins. Curr Opin Struct Biol 15:35-41.
134. Dunker AK, Cortese MS, Romero P, Iakoucheva LM, Uversky VN (2005) Flexible nets. The roles of intrinsic disorder in protein interaction networks. FEBS J 272:5129-5148.
135. Uversky VN (2003) Protein folding revisited. A polypeptide chain at the folding-misfolding-nonfolding cross-roads: which way to go? Cell Mol Life Sci 60:1852-1871.
136. Tompa P, Csermely P (2004) The role of structural disorder in the function of RNA and protein chaperones. FASEB J 18:1169-1175.
137. Tompa P, Szasz C, Buday L (2005) Structural disorder throws new light on moonlighting. Trends Biochem Sci 30:484-489.
138. Xie H, Vucetic S, Iakoucheva LM, Oldfield CJ, Dunker AK, Uversky VN, Obradovic Z (2007) Functional anthology of intrinsic disorder. I. Biological processes and functions of proteins with long disordered regions. J Proteome Res 6:1882-1898.
139. Xie H, Vucetic S, Iakoucheva LM, Oldfield CJ, Dunker AK, Obradovic Z, Uversky VN (2007) Functional anthology of intrinsic disorder. III. Ligands, post-translational modifications, and diseases associated with intrinsically disordered proteins. J Proteome Res 6:1917-1932.
140. Vucetic S, Xie H, Iakoucheva LM, Oldfield CJ, Dunker AK, Obradovic Z, Uversky VN (2007) Functional anthology of intrinsic disorder. II. Cellular components, domains, technical terms, developmental processes, and coding sequence diversities correlated with long disordered regions. J Proteome Res 6:1899- 1916.
141. Cortese MS, Uversky VN, Dunker AK (2008) Intrinsic disorder in scaffold proteins: getting more from less. Prog Biophys Mol Biol 98:85-106.
142. Dunker AK, Silman I, Uversky VN, Sussman JL (2008) Function and structure of inherently disordered proteins. Curr Opin Struct Biol 18:756-764.
143. Dunker AK, Uversky VN (2008) Signal transduction via unstructured protein conduits. Nat Chem Biol 4:229-230.
144. Dunker AK, Oldfield CJ, Meng J, Romero P, Yang JY, Chen JW, Vacic V, Obradovic Z, Uversky VN (2008) The unfoldomics decade: an update on intrinsically disordered proteins. BMC Genomics 9 (SUPPL. 2):S1.
145. Russell RB, Gibson TJ (2008) A careful disorderliness in the proteome: sites for interaction and targets for future therapies. FEBS Lett 582:1271-1275.
146. Tompa P, Fuxreiter M, Oldfield CJ, Simon I, Dunker AK, Uversky VN (2009) Close encounters of the third kind: disordered domains and the interactions of proteins. Bioessays 31:328-335.
147. Uversky VN, Dunker AK (2008) Biochemistry. Controlled chaos. Science 322:1340-1341.
148. Wright PE, Dyson HJ (2009) Linking folding and binding. Curr Opin Struct Biol 19:31-38.
149. Uversky VN (2012) Intrinsically disordered proteins from A to Z. Int J Biochem Cell Biol 43:1090-1103.
150. Dunker AK, Obradovic Z, Romero P, Kissinger C, Villafranca E (1997) On the importance of being disordered. PDB Newsletter 81:3-5.
151. Brown CJ, Takayama S, Campen AM, Vise P, Marshall TW, Oldfield CJ, Williams CJ, Dunker AK (2002) Evolutionary rate heterogeneity in proteins with long disordered regions. J Mol Evol 55:104-110.
152. Romero PR, Zaidi S, Fang YY, Uversky VN, Radivojac P, Oldfield CJ, Cortese MS, Sickmeier M, LeGall T, Obradovic Z, Dunker AK (2006) Alternative splicing in concert with protein intrinsic disorder enables increased functional diversity in multicellular organisms. Proc Natl Acad Sci USA 103:8390-8395.
153. Dosztanyi Z, Csizmok V, Tompa P, Simon I (2005) IUPred: web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content. Bioinformatics 21:3433-3434.
154. Spolar RS, Record MT, Jr. (1994) Coupling of local folding to site-specific binding of proteins to DNA. Science 263:777-784.
155. Schulz GE. Nucleotide binding proteins. In: Balaban M, Ed. (1979) Molecular mechanism of biological recognition. New York: Elsevier/North-Holland Biomedical Press, pp 79-94.
156. Pontius BW (1993) Close encounters: why unstructured, polymeric domains can increase rates of specific macromolecular association. Trends Biochem Sci 18:181-186.
157. Plaxco KW, Gross M (1997) Cell biology. The importance of being unfolded. Nature 386:657, 659.
158. Karush F (1950) Heterogeneity of the binding sites of bovine serum albumin. J Am Chem Soc 72:2705- 2713.
159. Kriwacki RW, Hengst L, Tennant L, Reed SI, Wright PE (1996) Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity. Proc Natl Acad Sci USA 93:11504-11509.
160. Ekman D, Light S, Bjorklund AK, Elofsson A (2006) What properties characterize the hub proteins of the protein-protein interaction network of Saccharomyces cerevisiae? Genome Biol 7:R45.
161. Haynes C, Oldfield CJ, Ji F, Klitgord N, Cusick ME, Radivojac P, Uversky VN, Vidal M, Iakoucheva LM (2006) Intrinsic disorder is a common feature of hub proteins from four eukaryotic interactomes. PLoS Comput Biol 2:e100.
162. Dosztanyi Z, Chen J, Dunker AK, Simon I, Tompa P (2006) Disorder and sequence repeats in hub proteins and their implications for network evolution. J Proteome Res 5:2985-2995.
163. Singh GP, Ganapathi M, Dash D (2007) Role of intrinsic disorder in transient interactions of hub proteins. Proteins 66:761-765.
164. Singh GP, Dash D (2007) Intrinsic disorder in yeast transcriptional regulatory network. Proteins 68:602-605.
165. Balazs A, Csizmok V, Buday L, Rakacs M, Kiss R, Bokor M, Udupa R, Tompa K, Tompa P (2009) High levels of structural disorder in scaffold proteins as exemplified by a novel neuronal protein, CASK-interactive protein1. FEBS J 276:3744-3756.
166. Jeffery CJ (1999) Moonlighting proteins. Trends Biochem Sci 24:8-11.
167. Jeffery CJ (2003) Multifunctional proteins: examples of gene sharing. Ann Med 35:28-35.
168. Jeffery CJ (2004) Molecular mechanisms for multitasking: recent crystal structures of moonlighting proteins. Curr Opin Struct Biol 14:663-668.
169. Hsu WL, Oldfield CJ, Xue B, Meng J, Huang F, Romero P, Uversky VN, Dunker AK (2013) Exploring the binding diversity of intrinsically disordered proteins involved in one-to-many binding. Protein Sci 22:258-273.
170. Watts DJ, Strogatz SH (1998) Collective dynamics of 'small-world' networks. Nature 393:440-442.
171. Goh KI, Oh E, Jeong H, Kahng B, Kim D (2002) Classification of scale-free networks. Proc Natl Acad Sci USA 99:12583-12588.
172. Barabasi AL, Albert R (1999) Emergence of scaling in random networks. Science 286:509-512.
173. Agarwal S, Deane CM, Porter MA, Jones NS (2010) Revisiting date and party hubs: novel approaches to role assignment in protein interaction networks. PLoS Comput Biol 6:e1000817.
174. Liu W, Rui H, Wang J, Lin S, He Y, Chen M, Li Q, Ye Z, Zhang S, Chan SC, Chen YG, Han J, Lin SC (2006) Axin is a scaffold protein in TGF-beta signaling that promotes degradation of Smad7 by Arkadia. EMBO J 25:1646-1658.
175. Liu J, Perumal NB, Oldfield CJ, Su EW, Uversky VN, Dunker AK (2006) Intrinsic disorder in transcription factors. Biochemistry 45:6873-6888.
176. Minezaki Y, Homma K, Kinjo AR, Nishikawa K (2006) Human transcription factors contain a high fraction of intrinsically disordered regions essential for transcriptional regulation. J Mol Biol 359:1137-1149.
177. Toth-Petroczy A, Oldfield CJ, Simon I, Takagi Y, Dunker AK, Uversky VN, Fuxreiter M (2008) Malleable machines in transcription regulation: the mediator complex. PLoS Comput Biol 4:e1000243.
178. Peng Z, Mizianty MJ, Xue B, Kurgan L, Uversky VN (2012) More than just tails: intrinsic disorder in histone proteins. Mol Biosyst 8:1886-1901.
179. Peng Z, Xue B, Mizianty MJ, Oldfield CJ, Kurgan L, Uversky VN (in press) A creature with hundred of waggly tails: intrinsically disordered proteins in ribosome. Biochim Biophys Acta Mol Cell Res.
180. Westerheide SD, Raynes R, Powell C, Xue B, Uversky VN (2012) HSF transcription factor family, heat shock response, and protein intrinsic disorder. Curr Protein Pept Sci 13:86-103.
181. Xue B, Oldfield CJ, Van YY, Dunker AK, Uversky VN (2012) Protein intrinsic disorder and induced pluripotent stem cells. Mol Biosyst 8:134-150.
182. Xue B, Dunker AK, Uversky VN (2012) The roles of intrinsic disorder in orchestrating the Wnt-pathway. J Biomol Struct Dyn 29:843-861.
183. Peng Z, Xue B, Kurgan L, Uversky VN (in press) Resilience of death: Intrinsic disorder in proteins involved in the programmed cell death. Cell Death Differ.
184. Pervushin K, Vamvaca K, Vogeli B, Hilvert D (2007) Structure and dynamics of a molten globular enzyme. Nat Struct Mol Biol 14:1202-1206.
185. Gatti-Lafranconi P, Hollfelder F (2013) Flexibility and reactivity in promiscuous enzymes. Chembiochem 14:285-292.
186. Karplus M (1984) Dynamics of proteins. Adv Biophys 18:165-190.
187. Hammes GG (2002) Multiple conformational changes in enzyme catalysis. Biochemistry 41:8221-8228.
188. Boehr DD, Dyson HJ, Wright PE (2006) An NMR perspective on enzyme dynamics. Chem Rev 106:3055- 3079.
189. Hammes-Schiffer S, Benkovic SJ (2006) Relating protein motion to catalysis. Annu Rev Biochem 75:519-541.
190. Olsson MH, Parson WW, Warshel A (2006) Dynamical contributions to enzyme catalysis: critical tests of a popular hypothesis. Chem Rev 106:1737-1756.
191. Koshland DE, Jr, Neet KE (1968) The catalytic and regulatory properties of enzymes. Annu Rev Biochem 37:359-410.
192. Vendruscolo M (2010) Enzymatic activity in disordered states of proteins. Curr Opin Chem Biol 14:671-675.
193. Vamvaca K, Vogeli B, Kast P, Pervushin K, Hilvert D (2004) An enzymatic molten globule: efficient coupling of folding and catalysis. Proc Natl Acad Sci USA 101:12860-12864.
194. Vamvaca K, Jelesarov I, Hilvert D (2008) Kinetics and thermodynamics of ligand binding to a molten globular enzyme and its native counterpart. J Mol Biol 382:971-977.
195. Woycechowsky KJ, Choutko A, Vamvaca K, Hilvert D (2008) Relative tolerance of an enzymatic molten globule and its thermostable counterpart to point mutation. Biochemistry 47:13489-13496.
196. Uversky VN, Kutyshenko VP, Protasova N, Rogov VV, Vassilenko KS, Gudkov AT (1996) Circularly permuted dihydrofolate reductase possesses all the properties of the molten globule state, but can resume functional tertiary structure by interaction with its ligands. Protein Sci 5:1844-1851.
197. Protasova N, Kireeva ML, Murzina NV, Murzin AG, Uversky VN, Gryaznova OI, Gudkov AT (1994) Circularly permuted dihydrofolate reductase of E. coli has functional activity and a destabilized tertiary structure. Protein Eng 7:1373-1377.
198. Zambelli B, Stola M, Musiani F, De Vriendt K, Samyn B, Devreese B, Van Beeumen J, Turano P, Dikiy A, Bryant DA, Ciurli S (2005) UreG, a chaperone in the urease assembly process, is an intrinsically unstructured GTPase that specifically binds Zn21. J Biol Chem 280:4684-4695.
199. Neyroz P, Zambelli B, Ciurli S (2006) Intrinsically disordered structure of Bacillus pasteurii UreG as revealed by steady-state and time-resolved fluorescence spectroscopy. Biochemistry 45:8918-8930.
200. Zambelli B, Cremades N, Neyroz P, Turano P, Uversky VN, Ciurli S (2012) Insights in the (un)structural organization of Bacillus pasteurii UreG, an intrinsically disordered GTPase enzyme. Mol Biosyst 8:220-228.
201. Uversky VN (2011) Multitude of binding modes attainable by intrinsically disordered proteins: a portrait gallery of disorder-based complexes. Chem Soc Rev 40:1623-1634.
202. Borg M, Mittag T, Pawson T, Tyers M, Forman-Kay JD, Chan HS (2007) Polyelectrostatic interactions of disordered ligands suggest a physical basis for ultrasensitivity. Proc Natl Acad Sci USA 104:9650-9655.
203. Mittag T, Orlicky S, Choy WY, Tang X, Lin H, Sicheri F, Kay LE, Tyers M, Forman-Kay JD (2008) Dynamic equilibrium engagement of a polyvalent ligand with a single-site receptor. Proc Natl Acad Sci USA 105:17772-17777.
204. Mittag T, Kay LE, Forman-Kay JD (2010) Protein dynamics and conformational disorder in molecular recognition. J Mol Recognit 23:105-116.
205. Mittag T, Marsh J, Grishaev A, Orlicky S, Lin H, Sicheri F, Tyers M, Forman-Kay JD (2010) Structure/ function implications in a dynamic complex of the intrinsically disordered Sic1 with the Cdc4 subunit of an SCF ubiquitin ligase. Structure 18:494-506.
206. Sigalov AB, Kim WM, Saline M, Stern LJ (2008) The intrinsically disordered cytoplasmic domain of the T cell receptor zeta chain binds to the nef protein of simian immunodeficiency virus without a disorder-toorder transition. Biochemistry 47:12942-12944.
207. Sigalov A, Aivazian D, Stern L (2004) Homooligomerization of the cytoplasmic domain of the T cell receptor zeta chain and of other proteins containing the immunoreceptor tyrosine-based activation motif. Biochemistry 43:2049-2061.
208. Sigalov AB, Zhuravleva AV, Orekhov VY (2007) Binding of intrinsically disordered proteins is not necessarily accompanied by a structural transition to a folded form. Biochimie 89:419-421.
209. Pometun MS, Chekmenev EY, Wittebort RJ (2004) Quantitative observation of backbone disorder in native elastin. J Biol Chem 279:7982-7987.
210. Sigalov AB, Hendricks GM (2009) Membrane binding mode of intrinsically disordered cytoplasmic domains of T cell receptor signaling subunits depends on lipid composition. Biochem Biophys Res Commun 389:388-393.
211. Sigalov AB, Aivazian DA, Uversky VN, Stern LJ (2006) Lipid-binding activity of intrinsically unstructured cytoplasmic domains of multichain immune recognition receptor signaling subunits. Biochemistry 45:15731-15739.
212. Hazy E, Tompa P (2009) Limitations of induced folding in molecular recognition by intrinsically disordered proteins. Chemphyschem 10:1415-1419.
213. Liu Y, Fratini E, Baglioni P, Chen WR, Chen SH (2005) Effective long-range attraction between protein molecules in solutions studied by small angle neutron scattering. Phys Rev Lett 95:118102.
214. Meyer TE, Yakali E, Cusanovich MA, Tollin G (1987) Properties of a water-soluble, yellow protein isolated from a halophilic phototrophic bacterium that has photochemical activity analogous to sensory rhodopsin. Biochemistry 26:418-423.
215. Hoff WD, van Stokkum IH, van Ramesdonk HJ, van Brederode ME, Brouwer AM, Fitch JC, Meyer TE, van Grondelle R, Hellingwerf KJ (1994) Measurement and global analysis of the absorbance changes in the photocycle of the photoactive yellow protein from Ectothiorhodospira halophila. Biophys J 67:1691- 1705.
216. Rubinstenn G, Vuister GW, Mulder FA, Dux PE, Boelens R, Hellingwerf KJ, Kaptein R (1998) Structural and dynamic changes of photoactive yellow protein during its photocycle in solution. Nat Struct Biol 5:568-570.
217. Ramachandran PL, Lovett JE, Carl PJ, Cammarata M, Lee JH, Jung YO, Ihee H, Timmel CR, van Thor JJ (2011) The short-lived signaling state of the photoactive yellow protein photoreceptor revealed by combined structural probes. J Am Chem Soc 133:9395- 9404.
218. Dux P, Rubinstenn G, Vuister GW, Boelens R, Mulder FA, Hard K, Hoff WD, Kroon AR, Crielaard W, Hellingwerf KJ, Kaptein R (1998) Solution structure and backbone dynamics of the photoactive yellow protein. Biochemistry 37:12689-12699.
219. Borgstahl GE, Williams DR, Getzoff ED (1995) 1.4 A structure of photoactive yellow protein, a cytosolic photoreceptor: unusual fold, active site, and chromophore. Biochemistry 34:6278-6287.
220. Gustin MC, Zhou XL, Martinac B, Kung C (1988) A mechanosensitive ion channel in the yeast plasma membrane. Science 242:762-765.
221. Corry B, Hurst AC, Pal P, Nomura T, Rigby P, Martinac B (2010) An improved open-channel structure of MscL determined from FRET confocal microscopy and simulation. J Gen Physiol 136:483-494.
222. Gsponer J, Futschik ME, Teichmann SA, Babu MM (2008) Tight regulation of unstructured proteins: from transcript synthesis to protein degradation. Science 322:1365-1368.
223. Grimmler M, Wang Y, Mund T, Cilensek Z, Keidel EM, Waddell MB, Jakel H, Kullmann M, Kriwacki RW, Hengst L (2007) Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases. Cell 128:269-280.
224. Iakoucheva LM, Radivojac P, Brown CJ, O'Connor TR, Sikes JG, Obradovic Z, Dunker AK (2004) The importance of intrinsic disorder for protein phosphorylation. Nucleic Acids Res 32:1037-1049.
225. Paliy O, Gargac SM, Cheng Y, Uversky VN, Dunker AK (2008) Protein disorder is positively correlated with gene expression in Escherichia coli. J Proteome Res 7:2234-2245.
226. Fernandez A, Scheraga HA (2003) Insufficiently dehydrated hydrogen bonds as determinants of protein interactions. Proc Natl Acad Sci USA 100:113-118.
227. Fernandez A (2004) Keeping dry and crossing membranes. Nat Biotechnol 22:1081-1084.
228. Kelly JW (1998) The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr Opin Struct Biol 8:101-106.
229. Dobson CM (1999) Protein misfolding, evolution and disease. Trends Biochem Sci 24:329-332.
230. Bellotti V, Mangione P, Stoppini M (1999) Biological activity and pathological implications of misfolded proteins. Cell Mol Life Sci 55:977-991.
231. Uversky VN, Talapatra A, Gillespie JR, Fink AL (1999) Protein deposits as the molecular basis of amyloidosis. I. Systemic amyloidoses. Med Sci Monitor 5:1001-1012.
232. Uversky VN, Talapatra A, Gillespie JR, Fink AL (1999) Protein deposits as the molecular basis of amyloidosis. II. Localized amyloidosis and neurodegenerative disordres. Med Sci Monitor 5:1238-1254.
233. Rochet JC, Lansbury PT, Jr (2000) Amyloid fibrillogenesis: themes and variations. Curr Opin Struct Biol 10:60-68.
234. Uversky VN, Fink AL (2004) Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim Biophys Acta 1698:131-153.
235. Uversky VN, Fink AL. Pathways to amyloid fibril formation: partially folded intermediates in fibrillation of unfolded proteins. In: Sipe JD, Ed. (2005) Amyloid proteins: the beta pleated sheet conformation and disease. Weinheim, Germany: Wiley-VCH, Verlag GmbH & Co. KGaA, pp 247-265.
236. Glenner GG, Wong CW (1984) Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 122:1131-1135.
237. Masters CL, Multhaup G, Simms G, Pottgiesser J, Martins RN, Beyreuther K (1985) Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J 4:2757- 2763.
238. Lee VM, Balin BJ, Otvos L, Jr, Trojanowski JQ (1991) A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science 251:675-678.
239. Ueda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DA, Kondo J, Ihara Y, Saitoh T (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 90:11282-11286.
240. Wisniewski KE, Dalton AJ, McLachlan C, Wen GY, Wisniewski HM (1985) Alzheimer's disease in Down's syndrome: clinicopathologic studies. Neurology 35:957-961.
241. Dev KK, Hofele K, Barbieri S, Buchman VL, van der Putten H (2003) Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease. Neuropharmacology 45:14-44.
242. Prusiner SB (2001) Shattuck lecture - neurodegenerative diseases and prions. N Engl J Med 344:1516- 1526.
243. Zoghbi HY, Orr HT (1999) Polyglutamine diseases: protein cleavage and aggregation. Curr Opin Neurobiol 9:566-570.
244. Okazawa H (2003) Polyglutamine diseases: a transcription disorder? Cell Mol Life Sci 60:1427-1439.
245. Cummings CJ, Zoghbi HY (2000) Fourteen and counting: unraveling trinucleotide repeat diseases. Hum Mol Genet 9:909-916.
246. Gusella JF, MacDonald ME (2000) Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease. Nat Rev Neurosci 1:109-115.
247. Orr HT (2001) Beyond the Qs in the polyglutamine diseases. Genes Dev 15:925-932.
248. Fischbeck KH (2001) Polyglutamine expansion neurodegenerative disease. Brain Res Bull 56:161-163.
249. Lee H, Mok KH, Muhandiram R, Park KH, Suk JE, Kim DH, Chang J, Sung YC, Choi KY, Han KH (2000) Local structural elements in the mostly unstructured transcriptional activation domain of human p53. J Biol Chem 275:29426-29432.
250. Adkins JN, Lumb KJ (2002) Intrinsic structural disorder and sequence features of the cell cycle inhibitor p57Kip2. Proteins 46:1-7.
251. Chang BS, Minn AJ, Muchmore SW, Fesik SW, Thompson CB (1997) Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2. EMBO J 16:968-977.
252. Campbell KM, Terrell AR, Laybourn PJ, Lumb KJ (2000) Intrinsic structural disorder of the C-terminal activation domain from the bZIP transcription factor Fos. Biochemistry 39:2708-2713.
253. Sunde M, McGrath KC, Young L, Matthews JM, Chua EL, Mackay JP, Death AK (2004) TC-1 is a novel tumorigenic and natively disordered protein associated with thyroid cancer. Cancer Res 64:2766- 2773.
254. Ng KP, Potikyan G, Savene RO, Denny CT, Uversky VN, Lee KA (2007) Multiple aromatic side chains within a disordered structure are critical for transcription and transforming activity of EWS family oncoproteins. Proc Natl Acad Sci USA 104:479-484.
255. Erkizan HV, Uversky VN, Toretsky JA (2010) Oncogenic partnerships: EWS-FLI1 protein interactions initiate key pathways of Ewing's sarcoma. Clin Cancer Res 16:4077-4083.
256. Anderson CW, Appella E. Signaling to the p53 tumor suppressor through pathways activated by genotoxic and nongenotoxic stress. In: Bradshaw RA, Dennis EA, Eds. (2004) Handbook of cell signaling. New York: Academic Press, pp 237-247.
257. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49-53.
258. Balint EE, Vousden KH (2001) Activation and activities of the p53 tumour suppressor protein. Br J Cancer 85:1813-1823.
259. Chene P (2004) Inhibition of the p53-hdm2 interaction with low molecular weight compounds. Cell Cycle 3:460-461.
260. Chene P (2004) Inhibition of the p53-MDM2 interaction: targeting a protein-protein interface. Mol Cancer Res 2:20-28.
261. Uversky VN, Oldfield CJ, Dunker AK (2008) Intrinsically disordered proteins in human diseases: introducing the D2 concept. Annu Rev Biophys 37:215-246.
262. Uversky VN, Oldfield CJ, Midic U, Xie H, Xue B, Vucetic S, Iakoucheva LM, Obradovic Z, Dunker AK (2009) Unfoldomics of human diseases: linking protein intrinsic disorder with diseases. BMC Genomics 10 (SUPPL. 1):S7.
263. Garner E, Romero P, Dunker AK, Brown C, Obradovic Z (1999) Predicting binding regions within disordered proteins. Genome Inform Ser Workshop Genome Inform 10:41-50.
264. Cheng Y, Oldfield CJ, Meng J, Romero P, Uversky VN, Dunker AK (2007) Mining alpha-helix-forming molecular recognition features with cross species sequence alignments. Biochemistry 46:13468-13477.
265. Oldfield CJ, Cheng Y, Cortese MS, Romero P, Uversky VN, Dunker AK (2005) Coupled folding and binding with alpha-helix-forming molecular recognition elements. Biochemistry 44:12454-12470.
266. Chen CT, Wagner H, Still WC (1998) Fluorescent, sequence-selective peptide detection by synthetic small molecules. Science 279:851-853.
267. Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ, Pavletich NP (1996) Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274:948-953.
268. Vassilev LT (2004) Small-molecule antagonists of p53- MDM2 binding: research tools and potential therapeutics. Cell Cycle 3:419-421.
269. Klein C, Vassilev LT (2004) Targeting the p53-MDM2 interaction to treat cancer. Br J Cancer 91:1415-1419.
270. Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, Kong N, Kammlott U, Lukacs C, Klein C, Fotouhi N, Liu EA (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303:844-848.
271. Cheng Y, LeGall T, Oldfield CJ, Mueller JP, Van YY, Romero P, Cortese MS, Uversky VN, Dunker AK (2006) Rational drug design via intrinsically disordered protein. Trends Biotechnol 24:435-442.
272. Arkin MR, Wells JA (2004) Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov 3:301-317.
273. Arkin M (2005) Protein-protein interactions and cancer: small molecules going in for the kill. Curr Opin Chem Biol 9:317-324.
274. Cochran AG (2000) Antagonists of protein-protein interactions. Chem Biol 7:R85-R94.
275. Hammoudeh DI, Follis AV, Prochownik EV, Metallo SJ (2009) Multiple independent binding sites for small-molecule inhibitors on the oncoprotein c-Myc. J Am Chem Soc 131:7390-7401.
276. Uversky VN (2011) Intrinsically disordered proteins may escape unwanted interactions via functional misfolding. Biochim Biophys Acta 1814:693-712.
277. Uversky VN (2012) Intrinsically disordered proteins and novel strategies for drug discovery. Expert Opin Drug Discov 7:475-488.
278. Stamm S, Ben-Ari S, Rafalska I, Tang Y, Zhang Z, Toiber D, Thanaraj TA, Soreq H (2005) Function of alternative splicing. Gene 344:1-20.
279. Oparin AI (1924) The origin of life (in Russian). Moscow: Moscow Worker publisher.
280. Haldane JBS. The origin of life. In: Watts CA, Ed. (1929) The rationalist annual for the year 1929. London: Watts & Co, pp 3-10.
281. Miller SL (1953) A production of amino acids under possible primitive earth conditions. Science 117:528-529.
282. Miller SL, Urey HC (1959) Organic compound synthesis on the primitive earth. Science 130:245-251.
283. Crick FH (1968) The origin of the genetic code. J Mol Biol 38:367-379.
284. Wong JT (1975) A co-evolution theory of the genetic code. Proc Natl Acad Sci USA 72:1909-1912.
285. Jukes TH (1973) Possibilities for the evolution of the genetic code from a preceding form. Nature 246:22-26.
286. Trifonov EN (2000) Consensus temporal order of amino acids and evolution of the triplet code. Gene 261:139-151.
287. Poole AM, Jeffares DC, Penny D (1998) The path from the RNA world. J Mol Evol 46:1-17.
288. Jeffares DC, Poole AM, Penny D (1998) Relics from the RNA world. J Mol Evol 46:18-36.
289. Treiber DK, Williamson JR (2001) Beyond kinetic traps in RNA folding. Curr Opin Struct Biol 11:309-314.
290. Cristofari G, Darlix JL (2002) The ubiquitous nature of RNA chaperone proteins. Prog Nucleic Acid Res Mol Biol 72:223-268.
291. Gilbert W (1986) Origin of life - the RNA world. Nature 319:618-618.
292. Csermely P (1997) Proteins, RNAs and chaperones in enzyme evolution: a folding perspective. Trends Biochem Sci 22:147-149.
293. Doolittle WF (2000) Uprooting the tree of life. Sci Am 282:90-95.
294. Theobald DL (2010) A formal test of the theory of universal common ancestry. Nature 465:219-222.
295. Chemes LB, Glavina J, Alonso LG, Marino-Buslje C, de Prat-Gay G, Sanchez IE (2012) Sequence evolution of the intrinsically disordered and globular domains of a model viral oncoprotein. PLoS One 7:e47661.
296. Chen SC, Chuang TJ, Li WH (2011) The relationships among microRNA regulation, intrinsically disordered regions, and other indicators of protein evolutionary rate. Mol Biol Evol 28:2513-2520.
297. Lin YS, Hsu WL, Hwang JK, Li WH (2007) Proportion of solvent-exposed amino acids in a protein and rate of protein evolution. Mol Biol Evol 24:1005-1011.
298. Shaiu WL, Hu T, Hsieh TS (1999) The hydrophilic, protease-sensitive terminal domains of eucaryotic DNA topoisomerases have essential intracellular functions. Pac Symp Biocomput:578-589.
299. Sayers EW, Gerstner RB, Draper DE, Torchia DA (2000) Structural preordering in the N-terminal region of ribosomal protein S4 revealed by heteronuclear NMR spectroscopy. Biochemistry 39:13602- 13613.
300. Wissmann R, Baukrowitz T, Kalbacher H, Kalbitzer HR, Ruppersberg JP, Pongs O, Antz C, Fakler B (1999) NMR structure and functional characteristics of the hydrophilic N terminus of the potassium channel beta-subunit Kvbeta1.1. J Biol Chem 274:35521- 35525.
301. Brown CJ, Johnson AK, Dunker AK, Daughdrill GW (2011) Evolution and disorder. Curr Opin Struct Biol 21:441-446.
302. Nilsson J, Grahn M, Wright AP (2011) Proteome-wide evidence for enhanced positive Darwinian selection within intrinsically disordered regions in proteins. Genome Biol 12:R65.
303. Breydo L, Wu JW, Uversky VN (2012) Alpha-synuclein misfolding and Parkinson's disease. Biochim Biophys Acta 1822:261-285.
304. George JM (2002) The synucleins. Genome Biol 3:REVIEWS3002.
305. Vonderviszt F, Kanto S, Aizawa S, Namba K (1989) Terminal regions of flagellin are disordered in solution. J Mol Biol 209:127-133.
306. Chen JW, Romero P, Uversky VN, Dunker AK (2006) Conservation of intrinsic disorder in protein domains and families. I. A database of conserved predicted disordered regions. J Proteome Res 5:879-887.
307. Chen JW, Romero P, Uversky VN, Dunker AK (2006) Conservation of intrinsic disorder in protein domains and families. II. functions of conserved disorder. J Proteome Res 5:888-898.
308. Xue B, Brown CJ, Dunker AK, Uversky VN (2013) Intrinsically disordered regions of p53 family are highly diversified in evolution. Biochim Biophys Acta 1834:725-738.
309. Daughdrill GW, Narayanaswami P, Gilmore SH, Belczyk A, Brown CJ (2007) Dynamic behavior of an intrinsically unstructured linker domain is conserved in the face of negligible amino acid sequence conservation. J Mol Evol 65:277-288.
310. Moesa HA, Wakabayashi S, Nakai K, Patil A (2012) Chemical composition is maintained in poorly conserved intrinsically disordered regions and suggests a means for their classification. Mol Biosyst 8:3262- 3273.